Dextrose And Sodium Chloride Injection, Solution
Product Images NDC 63323-873
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dextrose And Sodium Chloride (NDC 63323-873). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula (Dex1c 0000 02)
Fresenius Kabi Logo (Dex1c 0000 03)
Package Label (PRINCIPAL DISPLAY – Dextrose and Sodium Chloride 250 mL Bag Label)
This is a description of a pharmaceutical product labeled N, Freeflex® 250 mL, containing 5% dextrose and 0.225% sodium chloride injection, to be used intravenously, and available under Rxonly category. Each 100 ml of the product contains 5 g dextrose and 225 mg sodium chloride, in water for injection. The product comes in a single-dose container, and additives may be incompatible. The usual dosage should be referred to package insert. The overwrap of the container serves as a moisture barrier, and the product should be used immediately after removing the overwrap. It should be stored at 20-25°C (68º-77ºF), as per USP requirements, and must be protected from freezing. The container closure is not made with natural rubber latex, and is Non-PVC and Non-DEHP sterilized. The label includes NDC 63323-873-75 and (01)00363323873752, as well as information regarding the manufacturer, Fresenius Lot, located in Germany.*
Package Label (PRINCIPAL DISPLAY – Dextrose and Sodium Chloride 500 mL Bag Label)
The text describes a medication called freeflex, which is a solution of 5% Dextrose and 0.225% Sodium Chloride in water for injection. It is intended for intravenous use only and requires a prescription. The solution contains electrolytes such as sodium and chloride, and comes in a single-dose container that should be used immediately upon removal from the overwrap. The container closure is sterile and does not contain natural rubber latex, PVC, or DEHP. The text advises consulting a pharmacist if additives are to be introduced and provides storage instructions between 20-25°C. Manufacturer information is provided.*
Package Label (PRINCIPAL DISPLAY – Dextrose and Sodium Chloride 1000 mL Bag Label)
This is a description of a medication called "freeflex® 1000 mL 5% Dextrose and 0.225% Sodium Chloride Injection, USP" which contains dextrose and sodium chloride in water for injection. It is meant for intravenous use only and is available with a prescription. The medication comes in a single-dose container and should be used immediately once removed from the moisture barrier overwrap. It is recommended to store the medicine at a temperature between 20° to 25°C to protect it from freezing. The container closure is sterile and made without natural rubber latex, PVC, or DEHP. The usual dosage should be followed according to the labeled package insert, and additives may be incompatible, so it's vital to consult a pharmacist before introducing them.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.